🧪 Antibodies to ribonucleoprotein (RNP) are often found in systemic rheumatic diseases. High titres, especially Anti-U1RNP, are a hallmark of Mixed Connective Tissue Disease (MCTD) and help differentiate it from other autoimmune conditions.
🔎 About
- Types of RNP Antibodies:
- 🧬 RNP (Ribonucleoprotein): Autoantibodies directed against nuclear proteins bound to RNA molecules.
- 🎯 U1RNP: Targets U1 small nuclear ribonucleoprotein (snRNP) involved in RNA splicing - most clinically relevant subtype.
- Association with Anti-Sm: May co-exist with Anti-Smith antibodies, particularly in SLE, giving a more complex autoimmune profile.
📈 Elevated In
- Mixed Connective Tissue Disease (MCTD):
- ✅ Seen in 95–100% of cases; virtually diagnostic when titres are high.
- 🌈 Clinical overlap with lupus, scleroderma, and polymyositis.
- Features: Raynaud’s phenomenon ❄️, arthritis 🤲, myositis 💪.
- Systemic Lupus Erythematosus (SLE):
- 🩺 Often present but less specific than in MCTD.
- Associated with milder disease (arthralgia, rashes) unless co-existing with Anti-Sm.
- Progressive Systemic Sclerosis (PSS):
- Occasional positivity, usually in overlap syndromes.
- ⚠️ Linked with pulmonary hypertension and interstitial lung disease.
📌 Clinical Significance
- 🔬 Diagnosis: High titres virtually define MCTD.
- 📉 Prognosis: Suggests chronic but manageable course, especially in MCTD.
- 📊 Monitoring: Serial titres sometimes used to follow activity in MCTD/SLE.
🧪 Testing
- 💡 Indirect Immunofluorescence (ANA screen): Characteristic speckled pattern suggests RNP positivity.
- 🧾 ELISA: Confirms and quantifies antibody levels; more specific for U1RNP.
📚 References
- UpToDate: Mixed connective tissue disease overview.
- Oxford Handbook of Rheumatology.
- ARUP Laboratory Test Directory – Anti-U1RNP.